InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.55
(
0.17%
)
US TECH 100
19,426.00
(
0.12%
)
Dow Jones
38,795.88
(
0.05%
)
Brent Oil
84.43
(
0.63%
)
Bitcoin
64,468.33
(
-3.03%
)
Post# of 252245
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: genisi post# 150382

Wednesday, 10/10/2012 4:53:02 PM

Wednesday, October 10, 2012 4:53:02 PM

Post# of 252245
TEVA thrice-weekly Copaxone

Perhaps I should have clarified: time to generic launch is the key imo, because given Teva's aggressive sales promotion I think that even more than 25% of patients might switch to the thrice-weekly Copaxone but as soon as generic(s) enters, conversion will be very little.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up